INDUCED PLURIPOTENT STEM CELLS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120128655A1
SERIAL NO

13260897

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns the delivery of certain reprogramming factor proteins into cells, such as differenti-atedsomatic cells, in order to induce the epi-genetic reprogramming of the cell so it becomes a pluripotent stem cell. The reprogramming factor protein(s) may be Sox2, Klf4, Oct3/4, c-Myc, Lin28, Nanog, or any protein with reprogramming (-enhancing) activity. These proteins may be linked recombinantly or chemically to a cell penetrating peptide that helps facilitate the introduction of these proteins into the target cell and may be preferably expressed in mammalian cells to maintain them in active forms. Accordingly, the present method of inducing pluripotent stem cell (iPS) formation avoids the use of viral or DNA-based expression vectors or the expression of reprogramming factor genes within target cells, which are known to be harmful to the host target cell and cause cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE MCLEAN HOSPITAL CORPORATION115 MILL STREET BELMONT MA 02487

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Chun-Hyung Lexington, US 18 24
Kim, Dohoon Belmont, US 75 307
Kim, Kwang-Soo Lexington, US 140 1508

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation